MHRA sets out a developing approach to AI medical-device regulation
The UK medicines and health-products regulator outlined plans for adaptive rules, testing environments and international cooperation.
Event / data period: 2026-10-19
Published: · Updated:
In its 19 October announcement, MHRA said Deputy Director for AI and Software Jessica Paulsen would discuss the developing approach at the AdvaMed conference on 20 October. Plans include regulation that adapts over a device’s lifecycle, regulatory sandboxes and closer work with regulators in other countries.
The MHRA 2030 strategy envisages a modern framework for AI-enabled devices and a new Centre for AI and Digital Health. Its AI Airlock sandbox and NHS partnerships are already testing approaches; the announcement does not mean the plans constitute approval of any product.
Data
MHRA’s developing AI and medical-technology regulatory plans
Regulator’s account of a future framework, sandboxes and international coordination
- · Occurred
Announced measure
Measure stated in the official announcement
Methodology
Date and status follow the official source text.
Updated:
Subjects and places
Subject proposals
- Artificial intelligenceSuggested
- Subject suggested from the title or summary: AIwww.gov.uk ↗
- HealthSuggested
- Subject suggested from the title or summary: health, medicalwww.gov.uk ↗
Geographic references
Only source-provided geographic references are shown. Opening an external map is optional. Optional story maps use OpenStreetMap. Opening a map sends your IP address and this site’s address to the map provider; location data remains readable as text without loading the map.
- United Kingdom · Place role: Coverage · Place type: Country or area · Location precision: RegionalEvidence
- Explicit preserved editorial country/region; no city or national centroid inferredwww.gov.uk ↗